A Trial to Assess the Pharmacokinetic Similarity Between CHS-1420 40 mg/0.4 mL and HUMIRA® (Adalimumab) 40 mg/0.4 mL in Healthy Chinese Adult Participants Under Fasting Conditions

NCT07147257 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

238

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

BIOLOGICAL: CHS-1420
BIOLOGICAL: HUMIRA®

Sponsor

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.